Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou Huasheng Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company maintains a robust portfolio centered on small molecule therapeutics for cardiovascular diseases, gastrointestinal disorders, and anti-infectives. Operating with high-standard GMP-compliant facilities, Huasheng Pharmaceutical serves as a key supplier for both domestic Chinese markets and international pharmaceutical distributors. Their business model integrates chemical synthesis with pharmaceutical manufacturing to provide cost-effective generic medications and specialized chemical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changzhou Huasheng Pharmaceutical.